The "Compli' Asthme" therapeutic observation survey on good use of inhaled drugs for asthma: Perception by general practitioners;Enquête « Compli' Asthme »: Observance thérapeutique et bonne utilisation des médicaments inhalés l'asthme perçues par les médecins praticiens

Revue de Pneumologie Clinique

Volumn 60, Issue 3, 2004, Pages 158-165

  Megas, F ^a   Benmedjahed, K ^a   Lefranois G ^b   Mueser, M ^b   Dusser, D ^c  

^a MAPI VALUES   (United States)

^b Chiesi SA   (France)

^c Institut Cochin   (France)

Author keywords

Asthma; Corticophobia; France; Inhalation corticoid therapy; Inhalers; Therapeutic observance

Indexed keywords

BECLOMETASONE DIPROPIONATE; CORTICOSTEROID; BRONCHODILATING AGENT;

ADULT; AGED; ASTHMA; CHILD; CHILD BEHAVIOR; CONSULTATION; CORTICOPHOBIA; CORTICOSTEROID THERAPY; DRUG USE; FEMALE; FRANCE; GENERAL PRACTITIONER; GERIATRIC PATIENT; GOOD CLINICAL PRACTICE; HEALTH SURVEY; HORMONE DEPENDENCE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INHALER; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MEDICAL SPECIALIST; NORMAL HUMAN; PARENTAL BEHAVIOR; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT GUIDANCE; PATIENT PREFERENCE; PHOBIA; PRACTICE GUIDELINE; QUESTIONNAIRE; REVIEW; SIDE EFFECT; STEROID DEPENDENCE; ADOLESCENT; ARTICLE; CROSS-SECTIONAL STUDY; EPIDEMIOLOGY;

ADMINISTRATION, INHALATION; ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; ASTHMA; BRONCHODILATOR AGENTS; CHILD; CROSS-SECTIONAL STUDIES; FRANCE; HEALTH CARE SURVEYS; HUMANS; PATIENT COMPLIANCE; PHYSICIANS, FAMILY;

EID: 4043118952     PISSN: 07618417     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0761-8417(04)72091-x     Document Type: Review

References (34)

1. Com-Ruelle L, Crestin B, Dumesnil S. L'asthme en France selon les stades de sévérité. Paris: Credes, 2000.
2. Agence Nationale d'Accréditation et d'Evaluation en Santé (Anaes). Education thérapeutique du patient asthmatique, Adulte et Adolescent, Paris, juin 2001.
3. Charpim D, Annesi-Maesano I, Godard P. Présentation générale de l'́eude ISAAC. Rev Fr Allergol Immunol Clin 1998;537:1225-32.
4. European Community Respiratory Health Survey. Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, and use of asthma medication in the European Community Respiratory Health Survey (ECRHS). Eur Respir J 1996;9:687-95.
5. Bousquet J, Knani J, Henry C, Liard R, Richard A, Michel FB, et al. Undertreatment in a nonselected population of adult patients with asthma. J Allergy Clin Immunol 1996;98:514-21.
6. Liard R, Zureik M, Aubier M, Korobaeff M, Henry C, Neukirch F. Misuse of pressurized metered dose inhalers by asthmatic patients treated in French private practice. Rev Epidemiol Sante Publ 1995;43:242-9.
7. Liard R, Pin I, Bousquet J, Henry C, Pison C, Neukirch F. Prévalence de I'asthme chez les adultes jeunes en population générale (enquête dans 3 villes fraņaise). BEH 1995;45:197-8.
8. Liard R. Using global initiative for asthma guidelines to assess asthma severity in populations. Eur Respir J 2000;16:615-20.
9. Huchon G. Metered dose inhalers past and present: advantages and limitaions. Eur Respir Rev 1997;7:26-8.
10. Labrune S, Chinet T, Huchon G. Inhaled therapy in asthma: metered dose inhaler experience. Monaldi Arch Chest Dis 1994;49:254-7.
11. Roche N, Chinet T, Huchon G. Mise en route et surveillance d'un traitement inhalé dans les maladies bronchiques chroniques: aspects pratiques. Med Hyg 1996;792-8.
12. Métry JM. Measuring compliance in clinical trials and ambulatory care. In: Métry JM, Meyer UA, eds. Drug regimen compliance: issues in clinical trials and patient management. Chichester: John Wiley & Sons, 1999;1-21.
13. Dahan R, Dahan A, Cadranel J, Caulin C. La compliance: mesure de l'adhérence au traitement et au suivi thérapeutique. Therapie 1985;40:17-23.
14. Ankri J, Le Disert D, Henrard JC. Comportements individuels face aux médicaments. De l'observance thérapeutique àl'expé rience de la maladie. Analyse de la littérature. Santé Publique 1995;12:427-41.
15. Barr RG, Somers SC, Speizer FE, Camargo CA. Patient factors and medication guideline adherence among older women with asthma. Arch Intern Med 2002;162:1761-8.
16. Bender BG. Overcoming barriers to non-adherence in asthma treatment. J Allergy Clin Immunol 2002;109 (6 Suppl):S554-9.
17. Cluley S, Cochrane GM. Psychological disorder in asthma is associated with poor control and poor adherence to inhaled steroids. Respir Med 2001;95:37-9.
18. Buston KM, Wood SF. Non-compliance amongst adolescents with asthma: listening to what they tell us about self-management. Fam Pract 2000;17:134-8.
19. Schmaling KB, Afari N, Blume AW. Assessment of psychological factors associated with adherence to medication regimens among adult patients with asthma. J Asthma 2000;37:335-43.
20. Liard R, Soussan D, Zureik M, Touron D, Lepage T, Martinat Y, et al. Evolution sur 3 ans de l'asthme récemment diagnostiqué dans une cohorte d'enfants (étude ASMA). Facteurs liés à l'amélioration de l'état clinique. Presse Med 2002;31:637-43.
21. Scarfone RJ, Zorc JJ, Capraro GA. Patient self-management of acute asthma: adherence to national guidelines a decade later. Pediatrics 2001;108:1332-8.
22. Crim C. Clinical practice guidelines vs actual clinical practice: the asthma paradigm. Chest 2000;118(2 Suppl):62S-4S.
23. Jónasson G, Carlsen KH, Mowinckel P. Asthma drug adherence in a long-term clinical trial. Arch Dis Child 2000:83:330-3.
24. Bender B, Milgrom H, Rand C. Non-adherence in asthmatic patients: is there a solution to the problem? Ann Allergy Asthma Immunol 1997;79:177-85.
25. Creer TL, Levstek D. Medication compliance and asthma: over-looking the trees because of the forest. J Asthma 1996;33:203-11.
26. Weinberger M, Murray MD, Marrero DG, Brewer N, Lykens M, Harris LE, et al. Effectiveness of pharmacist care for patients with reactive airways disease: a randomized controlled trial. JAMA 2002;288:1594-602.
27. Morice AH, Wrench C. The role of the asthma nurse in treatment compliance and self-management following hospital admission. Respir Med 2001;95:851-6.
28. Serrier P, Muller D, Sevin C, Méchin H, Chanal I. Evaluation of an educational program on asthma for pharmacists. Presse Med 2000;29:1987-91.
29. Godding V, Kruth M, Jamart J. Joint consultation for high-risk asthmatic children and their families, with pediatrician and child psychiatrist as co-therapists: model and evaluation. Fam Process 1997;56:265-80.
30. Cochrane MG, Bala MV, Downs KE, Mauskopf J, Ben Joseph RH. Inhaled corticosteroids for asthma therapy: patient compliance, devices, and inhalation technique. Chest 2000;117:542-50.
31. Gut-Gobert C, Chenu E, Lemiere C, Leroyer C. Actualités de la prise en charge de la maladie asthmatique. Presse Med 2000;29:761-5.
32. David V, Mély L, Siret D, Dubus JC. Inhalation et nébulisation chez l'enfant. Arch Pediatr 2002;9 (Suppl 3):415S-21S.
33. Giraud V, Roche N. Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability. Eur Respir J 2002;19:246-51.
34. Vodoff MV, Gilbert B, de Lumley L, Dutau G. Technique d'utilisation de la chambre d'inhalation avec masque facial dans l'asthme. Évaluation chez 60 enfants âgés de moins de quatre ans. Arch Pediatr 2001;8;598-603.